ArticleScientific reports2023

HLA-DRB1*04:05 is involved in the development of Vogt-Koyanagi-Harada disease-like immune-related adverse events in patients receiving immune checkpoint inhibitors.

Masaki Takeuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.